New EPAC-paralegal, Heli Alasaari, at Laine IP

Laine IP’s patent paralegal Heli Alasaari succeeded in passing the third edition of the European patent administration certification-examination (EPAC) earlier this autumn. The examination is rather demanding, as it is not enough to have a long experience to pass it, one also needs to study hard.

The examination has two parts, a first part with multiple choice questions and a second part with open questions. The second part is corrected only if enough points is obtained in the first part.

Also this year the exam questions were partly very tricky, concerning also situation that one encounters rarely, if ever, in the work of a patent paralegal. A further challenge comes from the time pressure, as it is necessary in a short time to present answers to situations, part of which might be such that the candidate does not have any practical experience of them. Thus, in order to be successfull in the exam, one needs not only to have experience and study, but also to have steady nerves and good stress tolerance.

The persons who have passed this Europe-wide exam can thus refer to these four letters also in order to show proof of their knowledge.

Laine IP warmly congratulates Heli of this great achievement! We are glad that your are part of our team.

Referral G2/24 – Can the alleged infringer continue the appeal proceedings on their own?

The Patentee can start proceedings for infringement in a national court or the UPC. Similarly, a third party having received a request to cease alleged infringement can start proceedings in a court for a declaration of non-infringement.

In case opposition proceedings are pending at the EPO, this third party can intervene in the opposition proceedings, in certain conditions, within three months of the institution of the proceedings in a court. Intervention is also possible when the opposition proceedings are already in the second instance, i.e. an appeal is pending at the Board of Appeal.

A question on whether the intervener can continue the appeal proceedings on their own has been asked at the Enlarged Board of Appeal already previously (G3/04). In this case, the EBoA decided that if all original appellants withdraw their appeals, the appeal proceedings are terminated. The status of the intervener that joins the proceedings only at the appeal stage is thus at the moment different from that of the parties to the first instance proceedings.

 

New referral on the same issue

The question has been referred to the EBoA again, G2/24, based on the decision T1286/23 of the technical BoA. This decision criticises the earlier decision of the EBoA, i.a. as not being aligned with the Travaux Préparatoires of the EPC1973. The questions referred are as follows.

After withdrawal of all appeals, may the proceedings be continued with a third party who intervened during the appeal proceedings? In particular, may the third party acquire an appellant status corresponding to the status of a person entitled to appeal within the meaning of Article 107, first sentence, EPC?

The technical BoA proposes in its decision T1286/23 that an intervener that files their intervention during appeal proceedings could have three different statuses depending on the situation (reasons 3.9.4). The intervener would be a respondent, if the patent was revoked in the first instance (this would require the payment of opposition fee only, as an opponent does not have a right to appeal in such a situation); the intervener would have the same status as the appellant, if they pay the appeal fee in addition to the opposition fee; or the intervener would be a party as of right if they so wish and pay the opposition fee.

Currently, there is no basis in the EPC for the payment of appeal fee in this situation and therefore, it will be interesting to see how the EBoA will view such a proposal. As an alternative to the payment of the appeal fee, the technical BoA proposes that in case all appeals are withdrawn, the case is automatically remitted to first instance (reasons 3.16.2), which would leave the possibility to appeal for the intervener, should the decision of first instance not be as desired. This seems an option that would be easier to implement, not necessitating any changes in the Implementing Regulations

USPTO Increases fees – Major Impacts

The USPTO will increase selected fees and add new fees, effective January 19, 2025. According to the USPTO, “the fee adjustments are needed to provide the USPTO with sufficient aggregate revenue to recover the aggregate estimated costs of patent operations in future years.” See link to Federal Guidelines below.

 

A. Changes to Existing Fees

Most notably, the increases to existing fees include:

 

  1. US National Stage Application Fees

US National Application base filing fees will increase from 1,660 USD to 1,810 USD (664 USD to 724 USD for Small Entities).

table_application_fees

 

  1. US Non-National Stage Application (35 U.S.C. 111(a)) Fees

Base filing fees for Nonprovisional applications filed directly in the U.S. under 35 U.S.C. 111(a), including divisional or continuation applications of National Stage Applications, will increase from 1,820 USD to 2,000 USD (728 USD to 800 USD for Small Entities).

 

 

 

 

 

  1. Excess Claim Fees

Excess claim fees will significantly increase – double for excess claims over twenty (20)! Accordingly, it is highly recommended to reduce claims to 20 total / 3 independent claims, upon filing or shortly after filing.

 

  1. RCE (Request for Continued Examination) Fees

RCE fees will significantly increase as well, particularly for the 2nd+ RCE. Given the high cost of an RCE,  an Applicant may strongly wish to consider entering the Appeal process. For comparison, the costs for entering the Appeal process (fees of which will also increase) are also listed below.

 

 

 

 

 

 

  1. Extension Fees

Extension fees will increase as well, rendering non-timely filed responses more costly than ever.

 

 

 

 

  1. Issue Fee

The fee for proceeding from allowance to issuance of a US Patent (Issue Fee) will increase slightly: $1,200 -> $1,290 (Large Entity) and  $480 -> $516 (Small Entity).

 

B. New Fees

Effective January 19, 2025, there are also new fees for continuing applications (continuation, divisional, or continuation-in-part applications) filed over 6 years and 9 years from the application’s earliest benefit date, as well as new fees for IDS listings with over 50 cumulative cited references. The new fees are presented below:

 

  1. New Fees for Continuing Applications, based on earliest effective filing date.

Of note, the earliest benefit date (EBD) cannot be the filing date of a foreign application or the filing date of a provisional application to which benefit is claimed under  35 U.S.C. 119(e).

 

 

 

 

 

  1. New IDS Fees

There will be new fees, based on the total number of cited references to the USPTO in an IDS, when greater than fifty (50) references.

 

 

 

 

 

For more information and the specific fees, please see Federal Guidelines

If you have any questions on this article or on US patents generally, please contact a member of our US IP Team.

The USPTO terminates “After Final Consideration Pilot Program 2.0 (AFCP 2.0)”

The United States Patent and Trademark Office (USPTO) recently announced its decision to end its AFCP 2.0 Program. The last day to file a request for participation in the program will be December 14, 2024.

 

Was the AFCP 2.0 effective?

In our experience, acceptance into the AFCP 2.0 Program was relatively Examiner-dependent and subjective. When it worked, the AFCP 2.0 Program allowed the Applicant to make clarifying and/or “minor” substantive amendments to the claims After Final, while giving the Examiner at least some additional searching time. As such, Examiners were at least less likely to readily dismiss any substantive claim amendments (made after Final) in an Advisory Action as “requiring further search and consideration.”

 

Why the decision to terminate the AFCP 2.0 Program?

The AFCP 2.0 Program is being terminated for economical reasons. According to the USPTO, the AFCP 2.0 Program has allegedly led to significant administrative costs to the USPTO, and a proposed fee structure by the USPTO aimed at offsetting said costs was met by public resistance.

 

Now what?

The decision to terminate the AFCP 2.0 Program will likely require Applicant to even more carefully consider whether to make claim amendments after receiving a Final Office Action.

With the AFCP 2.0 Program gone, the After-Final options remain to do one or more of the following:

  1. Request an Interview with the Examiner before taking any further actions to try and come to an agreement as to arguments and/or amendments to overcome the current rejections of record;
  2. File an After Final Response with claim amendments and an RCE;
  3. File an After Final Response without any substantive claim amendments;
  4. File a Notice of Appeal along with or without a Pre-Appeal Brief to introduce a third party into the review process;
  5. File an Appeal Brief;
  6. File an additional application to pursue claims of different scope; and/or
  7. Abandon the application.

 

Strategies to make Examination More Efficient and Avoid RCE/Extension fees

There are pros and cons to each of the above strategies. The best strategy, however, is to try and avoid being in a position After Final where the Examiner has not yet examined any subject matter of importance to the Applicant. This is further of increased importance given the upcoming January 2025 USPTO fee increases, which will make the Request for Continued Examination (RCE) and Extension fees more costly than ever.

To reduce the likelihood of RCE and Extension fees, we strongly recommend reviewing the Specification and corresponding foreign applications and making amendments / adding new claims as needed at various stages before receiving a Final Office Action, namely:

  1. At the time of filing the US application;
  2. Prior to receiving a first Office Communication from the USPTO;
  3. If/when responding to a Restriction and/or Election of Species requirement; and/or
  4. If/when responding to a Non-Final Office Action

 

At Laine IP, we aim to make US patent prosecution as efficient and effective as possible, while meeting our clients’ business objectives. If you have any questions on this article or on US patents generally, please contact a member of our US IP Team.

 

MIP STARS 2024 | Laine IP Recognized in Top Tier for Patent and Trademark Excellence

IP STARS 2024: Laine IP Recognized in Top Tier for Patent and Trademark Excellence

We are excited to share that Laine IP has been recognized in the prestigious Tier 1 category for both patent and trademark services in the 2024 Managing Intellectual Property (MIP) rankings. This annual publication is renowned in the intellectual property realm, featuring evaluations based on comprehensive independent research involving feedback from clients and industry peers.

Achieving Tier 1 status for both our patent and trademark work highlights our commitment to our clients and their businesses. These recognitions reflect the positive experiences shared by our customers, highlighting our dedication to providing exceptional support.

Individual Honors

MIP Stars

In addition to our firm’s recognition, several of our experts have also been acknowledged individually. Tatu Ahlskog and Kathy Wasström have received MIP Stars in the patent category, while Joose Kilpimaa and Reijo Kokko have been honored in the trademark category.

Rising Stars

Furthermore, MIP celebrates emerging talent through its Rising Star awards. We are proud to announce that our European Patent Attorneys Tiia-Riikka Kittilä and Joni Vehmas, along with EU Trademark and Design Attorney Jemina Koskela, have all been recognized as Rising Stars for their significant contributions to their clients’ successes.

We congratulate all our recognized experts on this remarkable achievement!

A Heartfelt Thank You

At Laine IP, we are proud to be counted among the world’s leading intellectual property firms once again. We would like to express our gratitude to our clients and partners for their continued trust and support. We also want to acknowledge our dedicated team, whose commitment ensures the protection of our clients’ intellectual property rights.

Thank you for being a part of our journey!

 

UPC | Romania is the 18th member state

Unified Patent Court (UPC) has started its operation on June 1, 2023. The UPC system simplifies patenting in Europe such that it is possible to request for unitary effect for a granted European patent in the countries, which have ratified the Agreement on a Unified Patent Court (UPCA). A European patent with unitary effect may also be referred to as a Unitary Patent (UP).

The UPCA entered into force in Romania on 1 September 2024. It is therefore now possible to request for unitary effect for a granted European patent in 18 countries, which have ratified the UPCA.

The countries which have ratified the UPCA are at the moment (marked in the map): Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Portugal, Romania, Slovenia and Sweden.

We will continue to actively monitor the situation and get back to you, if there are any changes.

If you have any questions relating to the UPC, please contact our UPC experts at upc@laineip.fi

Our office will close on Friday 30 August at 12:00

Our office will close on Friday, 30th August exceptionally at 12:00 due to relocation of our Helsinki office to the 4th floor at our current address (Porkkalankatu 24). We will re-open normally on Monday, September 2 at 8.30 AM.

Our telephone numbers work normalwise, so in urgent matters you will reach our experts by phone (office: 09 6859 560).

We apologize for any inconvenience caused.

We have a new colleague

We’re excited to announce that Dr. Adam Herrala Bricker has joined our firm as a Patent Agent Trainee in our US IP Team. Adam holds a Bachelor of Science in Physics from Michigan State University in the U.S.; Master’s Degrees in Human Neuroscience and Philosophy; and a Ph.D. in Philosophy from the University of Edinburgh.

He joins our firm after last working as a Postdoctoral Researcher at the University of Turku, having previously held postdoctoral positions at the Universities of Oulu and Cologne, as well as a visiting researcher position at Dartmouth College. Additionally, Adam is fluent in several computer programming languages, especially Python for data processing and JavaScript for web development. Adam adds to our firm’s capabilities in assisting our clients with their US IP needs.

For further information, please contact Mark Scott +358504091218 or mark.scott@laineip.fi

Referral G1/24 – Is the description always to be used to interpret the claims?

The European Patent Office has traditionally been of the opinion that Article 69(1) EPC and the Protocol on the Interpretation of Article 69 EPC, according to which the extent of the protection conferred by an EP application or an EP patent is determined by the claims, but the description and drawings shall be used to interpret the claims, concerns courts of law, not the EPO itself, with the exception of broadening the scope of protection during opposition (Article 123(3)).

In the past years this opinion has however partly changed, and the opinions as well as the decisions of the Boards of Appeal have diverged at the EPO. Thus, a referral G1/24 has been made to the Enlarged Board of Appeal of the EPO, the referral being based on the decision T439/22 of a technical Board of Appeal. The referral asks the following three questions.

  1. Is Article 69(1), second sentence EPC and Article 1 of the Protocol on the Interpretation of Article 69 EPC to be applied on the interpretation of patent claims when assessing the patentability of an invention under Articles 52 to 57 EPC?
  2. May the description and figures be consulted when interpreting the claims to assess patentability and, if so, may this be done generally or only if the person skilled in the art finds a claim to be unclear or ambiguous when read in isolation?
  3. May a definition or similar information on a term used in the claims which is explicitly given in the description be disregarded when interpreting the claims to assess patentability and, if so, under what conditions?

The Court of Appeal of the UPC gave, in March 2024, a decision UPC_CoA_335/2023, according to which the description and drawings are always to be used to interpret the claims, instead of being used only for resolving unclarities. It will therefore be very interesting to see how the EBoA of the EPO answers the questions asked, which relate to the same issue. The EPO has on one hand said that they will follow decisions of the UPC and aim at harmonising decisions, but on the other hand, the Boards of Appeal of the EPO are independent and their decisions should be based only on the EPC and its Travaux Préparatoires. If the answers to the questions asked will be positive, i.e. that the description and claims are always to be used to interpret the claims, it will be fascinating to read, on which EPC Article or document of the Travaux Préparatoires the decision is based. It might simply be based on the use of the word “shall” in the second sentence of Article 69(1), but we’ll see.

The EPO has also already informed that despite this referral, examination and opposition proceedings will continue as normal, and will thus not be stayed until the decision is issued.

Laine IP maintains Silver ranking in new 2024 IAM 1000 listing

The 2024 edition of the IAM Patent 1000 Guide has now been published, which includes recommended patent law firms and a listing of 1000 standout patent practitioners across the globe.

We are pleased to share that Laine IP has maintained a Silver ranking and been provided with excellent reviews in the Patent Prosecution category.

In addition, firm Managing Director and European Patent Attorney, Jouni Smolander; European patent attorneys, Kaisa Suominen, Jarkko Tiilikainen, Hanna Laurén, and Kathy Wasström, and two of our U.S. patent professionals, Mark Scott and Toimi Teelahti (also a European Patent Attorney), were individually named as Recommended Practitioners in the 2024 IAM Patent 1000’s listing of 1000 standout practitioners across the globe.

A link to the 2024 IAM 1000 Guide and Laine IP’s recognitions can be found here.

We sincerely appreciate our clients’ continued trust in our firm and their feedback in IAM’s selection process.